Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2000
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2361816A1 Substituted pyrazole carboxylic acids used to combat anaemias
08/10/2000CA2361805A1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same
08/10/2000CA2361589A1 Calcilytic compounds
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2361539A1 Compressed lecithin preparations
08/10/2000CA2361459A1 Use of cationic lipids to generate anti-tumor immunity
08/10/2000CA2361191A1 Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
08/10/2000CA2360942A1 Preparations for preventing and/or treating a tissue change of mesenchymal origin
08/10/2000CA2360941A1 Liposome composition and method for administration of a radiosensitizer
08/10/2000CA2360893A1 Tau-conotoxin peptides
08/10/2000CA2360878A1 Gene repair involving excision of targeting dna
08/10/2000CA2360865A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
08/10/2000CA2360796A1 Improved helper dependent vector system for gene therapy
08/10/2000CA2360684A1 Method for inducing differentiation into adipocytes, compounds controlling such differentiation and method of screening for same
08/10/2000CA2358895A1 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
08/10/2000CA2358894A1 Tricyclic pyridine n-oxides vasopressin agonists
08/10/2000CA2358892A1 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
08/10/2000CA2358891A1 Thienylbenzoylbenzazepines as vasopressin agonists
08/10/2000CA2358855A1 Benzazepine derivatives as alpha-v integrin receptor antagonists
08/10/2000CA2357013A1 Anti-inflammatory indole derivatives
08/10/2000CA2356898A1 Indole derivatives and their use as mcp-1 antagonists
08/09/2000EP1026253A2 Expression of exogenous polynucleotide sequences in a vertebrate
08/09/2000EP1026157A2 Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
08/09/2000EP1025871A1 Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
08/09/2000EP1025849A1 Methods for detection and treatment of individuals having abnormal cells expressing HLA-A2/tyrosinase peptide antigens
08/09/2000EP1025834A1 Use for direct hair dye a combination of two cationic dyes
08/09/2000EP1025238A2 Death associated kinase containing ankyrin repeats (dakar)
08/09/2000EP1025231A1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance
08/09/2000EP1025216A1 Transgenic animal models for cardiac hypertrophy and uses thereof
08/09/2000EP1025211A2 Hyaluronan synthase gene and uses thereof
08/09/2000EP1025122A1 Fibroblast growth factor with hepatocyte proliferation activity
08/09/2000EP1025109A1 Benzoxazine derivatives, preparation and application in therapy
08/09/2000EP1025105A1 Condensed benzothiopyranic compounds
08/09/2000EP1025103A1 Novel polymorphic forms of cipamfylline
08/09/2000EP1025102A1 Bicyclic kinase inhibitors
08/09/2000EP1025100A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
08/09/2000EP1025098A1 Benzothiophenes
08/09/2000EP1025090A1 Vitronectin receptor antagonists
08/09/2000EP1025087A1 Substituted isoquinoline derivatives and their use as anticonvulsants
08/09/2000EP1025086A1 Benzamidine derivatives as factor xa inhibitors
08/09/2000EP1025085A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
08/09/2000EP1024823A1 Prevention and treatment of adhesion formation
08/09/2000EP1024822A1 Cd8 as an inhibitor of the cellular immune system
08/09/2000EP1024819A1 Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
08/09/2000EP1024815A1 Pharmaceutical compositions for oral administration of molecular iodine
08/09/2000EP1024813A1 Use of sulfated oligosaccharides as inhibitors of cardiovascular disease
08/09/2000EP1024809A1 Use of immunomodulating agents
08/09/2000EP1024806A1 Use of non-immunosuppressive compounds for promoting nerve regeneration
08/09/2000EP1024804A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
08/09/2000EP1024802A1 (3$i(R),4$i(R))-$g(D)-TETRAHYDROCANNABINOL-11-OIC ACIDS USEFUL AS ANTIINFLAMMATORY AGENTS AND ANALGESICS
08/09/2000EP1024801A2 Method for regulating size and growth of vascularized normal tissue
08/09/2000EP1024799A1 Method for treating disease-related or drug-induced dyskinesias
08/09/2000EP1024798A1 Neomycin/disaccharide water solution for enteroclysis in hepatic encephalopathy
08/09/2000EP1024701A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
08/09/2000EP0820434B1 Phenoxyethylamine derivatives having high affinity for the 5-ht 1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives
08/09/2000EP0734384B1 3-substituted 1-arylindole compounds
08/09/2000EP0732915B1 Local delivery of fibrinolysis enhancing agents
08/09/2000EP0642519B1 Sulfur-containing phosponate compounds for treating abnormal calcium and phosphate metabolism
08/09/2000EP0642513B1 Indolocarbazole imides and their use
08/09/2000EP0641201B1 Renewal of extrinsic aging of the skin by transdermal application of selenoamino acids
08/09/2000EP0533846B1 The ciliary neurotrophic factor receptor
08/09/2000CN1262681A 4,5-dihydro-[1H]-benz [g] indazole-3-carboxylic acid derivatives
08/09/2000CN1262680A 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
08/09/2000CN1262679A IL-5 inhibiting 6-azauracil derivatives
08/09/2000CN1262678A Triazole compounds and use thereof as dopamine-D3-ligands
08/09/2000CN1262677A Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, noval compounds thereof and their use as chemotherapeutic agents
08/09/2000CN1262676A 吡啶衍生物 Pyridine derivatives
08/09/2000CN1262675A (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers
08/09/2000CN1262674A Gatrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
08/09/2000CN1262627A Composition
08/09/2000CN1262624A Use of colchinol derivatives as vascular damaging agents
08/09/2000CN1262621A Gastrokinetic bicyclc benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
08/09/2000CN1262600A Compositions and method for reducing respiratory depression and attendant side effects of mu opioid compounds
08/09/2000CN1262272A HIV proteinase inhibitor
08/09/2000CN1262120A Medicinal ox horn
08/09/2000CN1055213C Health-care medicinal liquor
08/08/2000US6100387 Chimeric polypeptides containing chemokine domains
08/08/2000US6100299 Tumor necrosis factor inhibitor; anticarcinogenic agents, antiinflammatory agents
08/08/2000US6100297 Administering antioxidant cardioplegic solution during coronary bypass surgery
08/08/2000US6100294 For treatment of metabolic, glandular, and bone disorders caused by vitamin deficiency
08/08/2000US6100289 Indole derivatives
08/08/2000US6100284 Antiallergens
08/08/2000US6100283 Prodrug phosphate derivative for poly (adp-ribose) polymerase enzyme inhibitor for administering in conjunction with antitumor drug or radiotherapy
08/08/2000US6100282 Thiazole derivatives
08/08/2000US6100278 N-(arylsulphonyl)amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
08/08/2000US6100277 Retroviral protease inhibitor combinations
08/08/2000US6100273 Water soluble camptothecin derivatives
08/08/2000US6100272 Tetracyclic spiro compounds as 5HT1B receptor antagonists
08/08/2000US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents
08/08/2000US6100270 Bicyclic heterocyclic compounds for the treatment of impotence
08/08/2000US6100267 Enzyme inhibitor for treatment of neurodegenerative disorders, strokes, traumatic brain injury, cataracts
08/08/2000US6100264 5H, 10H-imidazo [1,2-A] indeno [1,2-E] pyrazin-4-one derivatives, their preparation, their intermediates and medicaments containing them
08/08/2000US6100259 Cannabinoid receptor modulators
08/08/2000US6100252 Specified compounds including methyl 2-butyl-1-((2'-(2-oxo-3h-1,2,3,5-oxathiadiazol-4-yl)biphenyl) methyl)-benzimidazole-7-carboxylate; use to treat circulatory diseases such as hypertensive diseases and heart diseases
08/08/2000US6100249 Use of aspirin for the manufacture of a medicament for implanting an embryo into the uterine endometrium
08/08/2000US6100246 Spiro-piperidine derivatives as inhibitors of nitric oxide synthase
08/08/2000US6100237 Use of des-Aspartate-angiotensin I as an agent for the treatment and prevention of neointima formation, restenosis, and arteriosclerosis
08/08/2000US6100059 Compounds
08/08/2000US6100048 Using a panel of mammalian cells transformed with recombinant expression constructs encoding a variety of melanocortin receptors; contacting cells with compound, detecting binding, and determing if compound inhibits feeding behavior